AMINOLEVULINIC ACID HYDROCHLORIDE

AMINOLEVULINIC ACID HYDROCHLORIDE was reported 1746 times

These side effects are most commonly reported by patients taking AMINOLEVULINIC ACID HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 290
1 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 182
2 POOR QUALITY PRODUCT ADMINISTERED 177
3 PRODUCT QUALITY ISSUE 153
4 PRODUCT DOSE OMISSION ISSUE 114
5 ERYTHEMA 106
6 ACCIDENTAL EXPOSURE TO PRODUCT 80
7 OFF LABEL USE 79
8 PAIN 63
9 PRODUCT PHYSICAL ISSUE 62
10 BLISTER 50
11 APPLICATION SITE PAIN 42
12 APPLICATION SITE ERYTHEMA 35
13 SKIN EXFOLIATION 35
14 PRODUCT PACKAGING QUANTITY ISSUE 34
15 HYPOTENSION 33
16 BURNING SENSATION 29
17 EYE IRRITATION 29
18 LIQUID PRODUCT PHYSICAL ISSUE 29
19 PHOTOSENSITIVITY REACTION 25
20 TREATMENT FAILURE 25
21 SWELLING FACE 22
22 THERAPY NON-RESPONDER 21
23 SWELLING 20
24 PRODUCT USE ISSUE 19
25 SKIN BURNING SENSATION 18
26 EYE PAIN 17
27 LACRIMATION INCREASED 17
28 EYE SWELLING 16
29 PHOTOPHOBIA 16
30 APPLICATION SITE SWELLING 15
31 DEVICE ISSUE 15
32 VISION BLURRED 15
33 APPLICATION SITE REACTION 14
34 NAUSEA 14
35 NONSPECIFIC REACTION 14
36 PRODUCT COMPLAINT 14
37 PRODUCT LEAKAGE 14
38 SUNBURN 14
39 APPLICATION SITE VESICLES 13
40 LACERATION 13
41 PRURITUS 13
42 THERAPEUTIC RESPONSE DECREASED 13
43 VOMITING 13
44 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12
45 DISCOMFORT 11
46 DRY EYE 11
47 HEADACHE 11
48 INCORRECT DOSE ADMINISTERED 11
49 PRODUCT ADMINISTRATION ERROR 11
50 PRODUCT CONTAINER ISSUE 11
51 APPLICATION SITE EXFOLIATION 10
52 DEVICE DEFECTIVE 10
53 DEVICE MALFUNCTION 10
54 HYPERSENSITIVITY 10
55 DERMATITIS ACNEIFORM 9
56 FEELING HOT 9
57 PRODUCT DOSE OMISSION 9
58 PRODUCT PACKAGE ASSOCIATED INJURY 9
59 PRODUCT STORAGE ERROR 9
60 RASH ERYTHEMATOUS 9
61 VISUAL IMPAIRMENT 9
62 ACNE 8
63 ALOPECIA 8
64 APPLICATION SITE BURN 8
65 EYE BURNS 8
66 FATIGUE 8
67 MALAISE 8
68 OCULAR HYPERAEMIA 8
69 PYREXIA 8
70 SEIZURE 8
71 SKIN LACERATION 8
72 SUSPECTED COUNTERFEIT PRODUCT 8
73 THERAPY INTERRUPTED 8
74 APPLICATION SITE DISCOLOURATION 7
75 APPLICATION SITE PUSTULES 7
76 APPLICATION SITE SCAB 7
77 BLOOD PRESSURE DECREASED 7
78 CARDIAC ARREST 7
79 DIZZINESS 7
80 INFLAMMATION 7
81 RASH MACULO-PAPULAR 7
82 RASH MORBILLIFORM 7
83 SCAB 7
84 TYPE IV HYPERSENSITIVITY REACTION 7
85 AMNESIA 6
86 APPLICATION SITE PRURITUS 6
87 ATRIAL FIBRILLATION 6
88 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6
89 DEVICE BREAKAGE 6
90 INJURY 6
91 INSOMNIA 6
92 LOSS OF CONSCIOUSNESS 6
93 OVERDOSE 6
94 PACKAGING DESIGN ISSUE 6
95 PARAESTHESIA 6
96 PRODUCT PACKAGING ISSUE 6
97 PRODUCT USE COMPLAINT 6
98 RASH 6
99 RASH MACULAR 6
100 SKIN WRINKLING 6
101 CHEST PAIN 5
102 CONDITION AGGRAVATED 5
103 DISEASE RECURRENCE 5
104 DISORIENTATION 5
105 DRY SKIN 5
106 FACIAL PAIN 5
107 FEELING ABNORMAL 5
108 HAEMORRHAGE 5
109 HEPATIC FUNCTION ABNORMAL 5
110 INFECTION 5
111 PIGMENTATION DISORDER 5
112 PRODUCT DEPOSIT 5
113 PRODUCT PHYSICAL CONSISTENCY ISSUE 5
114 SHOCK 5
115 SKIN DISCOLOURATION 5
116 WOUND 5
117 ACUTE RESPIRATORY DISTRESS SYNDROME 4
118 ADMINISTRATION SITE PAIN 4
119 BLEPHARITIS 4
120 BLOOD GLUCOSE INCREASED 4
121 BURNS FIRST DEGREE 4
122 CHEMICAL BURN 4
123 CONTUSION 4
124 DERMATITIS CONTACT 4
125 DEVICE OPERATIONAL ISSUE 4
126 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4
127 DYSGEUSIA 4
128 DYSPHAGIA 4
129 DYSPNOEA 4
130 EYE DISORDER 4
131 EYE PRURITUS 4
132 HERPES ZOSTER 4
133 HYPERKERATOSIS 4
134 OCULAR DISCOMFORT 4
135 PNEUMONIA 4
136 POST PROCEDURAL COMPLICATION 4
137 PRODUCT COMMUNICATION ISSUE 4
138 RASH VESICULAR 4
139 SCAR 4
140 SCRATCH 4
141 SKIN IRRITATION 4
142 SKIN WEEPING 4
143 TACHYCARDIA 4
144 THERAPY CESSATION 4
145 UNDERDOSE 4
146 VITREOUS FLOATERS 4
147 ALTERED STATE OF CONSCIOUSNESS 3
148 BLINDNESS UNILATERAL 3
149 BRADYCARDIA 3
150 BRAIN OEDEMA 3
151 BURNS SECOND DEGREE 3
152 CHEST DISCOMFORT 3
153 CONFUSIONAL STATE 3
154 DERMATITIS 3
155 DRUG HYPERSENSITIVITY 3
156 DRUG INTOLERANCE 3
157 FEELING OF BODY TEMPERATURE CHANGE 3
158 FLUSHING 3
159 HAIR COLOUR CHANGES 3
160 HALLUCINATION 3
161 MEMORY IMPAIRMENT 3
162 OXYGEN SATURATION DECREASED 3
163 PATIENT DISSATISFACTION WITH TREATMENT 3
164 PRESYNCOPE 3
165 PRODUCT LABEL ISSUE 3
166 PUSTULE 3
167 RASH PUSTULAR 3
168 SKIN CANCER 3
169 SKIN DISCOMFORT 3
170 SKIN HYPERPIGMENTATION 3
171 STAPHYLOCOCCAL INFECTION 3
172 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
173 TOOTHACHE 3
174 TREATMENT NONCOMPLIANCE 3
175 URTICARIA 3
176 WHITE BLOOD CELL COUNT DECREASED 3
177 ACUTE MYOCARDIAL INFARCTION 2
178 ADMINISTRATION SITE DISCOMFORT 2
179 ADMINISTRATION SITE ERYTHEMA 2
180 ADVERSE REACTION 2
181 ANAPHYLACTIC REACTION 2
182 ANGIOEDEMA 2
183 ANXIETY 2
184 APHASIA 2
185 APPLICATION SITE DRYNESS 2
186 APPLICATION SITE HAEMORRHAGE 2
187 APPLICATION SITE INFECTION 2
188 APPLICATION SITE IRRITATION 2
189 APPLICATION SITE PAPULES 2
190 APPLICATION SITE RASH 2
191 ARRHYTHMIA 2
192 ASTHENIA 2
193 BACK DISORDER 2
194 BASAL CELL CARCINOMA 2
195 BLOOD CREATININE INCREASED 2
196 BLOOD PRESSURE INCREASED 2
197 CARDIO-RESPIRATORY ARREST 2
198 CATARACT 2
199 CEREBRAL INFARCTION 2
200 CHALAZION 2
201 CHILLS 2
202 CONVULSION 2
203 DACRYOSTENOSIS ACQUIRED 2
204 DEVICE FAILURE 2
205 DEVICE USE ISSUE 2
206 DIABETIC KETOACIDOSIS 2
207 EMBOLIC STROKE 2
208 EPISTAXIS 2
209 EXPIRED PRODUCT ADMINISTERED 2
210 FALL 2
211 FOREIGN BODY SENSATION IN EYES 2
212 HEART RATE DECREASED 2
213 HEPATIC ENZYME INCREASED 2
214 ILLNESS 2
215 IMPAIRED HEALING 2
216 INCORRECT DRUG ADMINISTRATION DURATION 2
217 INCORRECT PRODUCT ADMINISTRATION DURATION 2
218 INFLUENZA LIKE ILLNESS 2
219 INJURY ASSOCIATED WITH DEVICE 2
220 IRRITABILITY 2
221 KERATITIS 2
222 LIMB INJURY 2
223 LIP BLISTER 2
224 LIP SWELLING 2
225 LIVER DISORDER 2
226 MANUFACTURING ISSUE 2
227 MANUFACTURING MATERIALS ISSUE 2
228 MEDICATION ERROR 2
229 MYOCARDIAL INFARCTION 2
230 OCCUPATIONAL EXPOSURE TO PRODUCT 2
231 OPTIC NERVE INJURY 2
232 ORAL DISCOMFORT 2
233 PAIN OF SKIN 2
234 PHOTOPSIA 2
235 PLATELET COUNT DECREASED 2
236 PRECANCEROUS CONDITION 2
237 PRECANCEROUS SKIN LESION 2
238 PRODUCT CONTAMINATION PHYSICAL 2
239 PRODUCT DISPENSING ERROR 2
240 PRODUCT PACKAGING CONFUSION 2
241 PRODUCT PREPARATION ERROR 2
242 PRODUCT USE IN UNAPPROVED INDICATION 2
243 PULMONARY THROMBOSIS 2
244 RASH PAPULAR 2
245 RESPIRATORY FAILURE 2
246 RHINORRHOEA 2
247 ROSACEA 2
248 SENSITIVE SKIN 2
249 SEPTIC SHOCK 2
250 SKIN REACTION 2
251 SKIN SWELLING 2
252 SKIN TIGHTNESS 2
253 SLEEP DISORDER 2
254 SUBDURAL HAEMATOMA 2
255 SWELLING OF EYELID 2
256 SWOLLEN TONGUE 2
257 SYNCOPE 2
258 THERAPEUTIC RESPONSE UNEXPECTED 2
259 THERMAL BURN 2
260 THROAT IRRITATION 2
261 THROMBOCYTOPENIA 2
262 TRANSIENT ISCHAEMIC ATTACK 2
263 TREMOR 2
264 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 2
265 VIRAL SEPSIS 2
266 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2
267 ABDOMINAL DISCOMFORT 1
268 ABDOMINAL PAIN UPPER 1
269 ABNORMAL BEHAVIOUR 1
270 ABNORMAL LOSS OF WEIGHT 1
271 ACCIDENT 1
272 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1
273 ACCIDENTAL OVERDOSE 1
274 ACNE CYSTIC 1
275 ACUTE KIDNEY INJURY 1
276 ADMINISTRATION SITE DISCOLOURATION 1
277 ADMINISTRATION SITE OEDEMA 1
278 ADMINISTRATION SITE SWELLING 1
279 ADVERSE DRUG REACTION 1
280 ADVERSE EVENT 1
281 AGGRESSION 1
282 ALANINE AMINOTRANSFERASE INCREASED 1
283 ALCOHOL USE 1
284 ALLERGY TO METALS 1
285 AMYLASE INCREASED 1
286 ANAEMIA 1
287 ANAPHYLACTIC SHOCK 1
288 ANGER 1
289 ANNULAR ELASTOLYTIC GIANT CELL GRANULOMA 1
290 APPLICATION SITE BRUISE 1
291 APPLICATION SITE DISCOMFORT 1
292 APPLICATION SITE DYSAESTHESIA 1
293 APPLICATION SITE FISSURE 1
294 APPLICATION SITE INFLAMMATION 1
295 APPLICATION SITE LACERATION 1
296 APPLICATION SITE OEDEMA 1
297 APPLICATION SITE PHOTOSENSITIVITY REACTION 1
298 APPLICATION SITE SCAR 1
299 APPLICATION SITE STREAKING 1
300 APPLICATION SITE WARMTH 1
301 APRAXIA 1
302 ARTHRALGIA 1
303 ASPARTATE AMINOTRANSFERASE INCREASED 1
304 ASTHENOPIA 1
305 BACK PAIN 1
306 BACTERAEMIA 1
307 BALANCE DISORDER 1
308 BLINDNESS TRANSIENT 1
309 BLISTER RUPTURE 1
310 BLOOD BILIRUBIN INCREASED 1
311 BLOOD KETONE BODY PRESENT 1
312 BRAIN FOG 1
313 BRAIN TUMOUR OPERATION 1
314 BRUXISM 1
315 BUNDLE BRANCH BLOCK LEFT 1
316 CAPILLARY FRAGILITY 1
317 CARDIAC FAILURE ACUTE 1
318 CELLULITIS 1
319 CEREBRAL HAEMORRHAGE 1
320 CEREBROSPINAL FLUID RETENTION 1
321 CEREBROVASCULAR ACCIDENT 1
322 CHAPPED LIPS 1
323 CHROMATURIA 1
324 CNS VENTRICULITIS 1
325 COLLAGEN DISORDER 1
326 CONJUNCTIVITIS 1
327 CONTRAINDICATED PRODUCT ADMINISTERED 1
328 CORNEAL DISORDER 1
329 COUNTERFEIT PRODUCT ADMINISTERED 1
330 CRYING 1
331 DARK CIRCLES UNDER EYES 1
332 DEATH 1
333 DECREASED ACTIVITY 1
334 DECREASED APPETITE 1
335 DEEP VEIN THROMBOSIS 1
336 DEFORMITY OF ORBIT 1
337 DEHYDRATION 1
338 DELIRIUM 1
339 DEPRESSED LEVEL OF CONSCIOUSNESS 1
340 DEPRESSED MOOD 1
341 DERMATITIS PSORIASIFORM 1
342 DERMATOSIS 1
343 DEVICE DELIVERY SYSTEM ISSUE 1
344 DEVICE DISPENSING ERROR 1
345 DEVICE ELECTRICAL FINDING 1
346 DIPLOPIA 1
347 DRUG ADMINISTRATION ERROR 1
348 DRUG EFFECT INCOMPLETE 1
349 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1
350 DRUG MONITORING PROCEDURE NOT PERFORMED 1
351 DRUG WITHDRAWAL SYNDROME 1
352 DYSARTHRIA 1
353 DYSCHROMATOPSIA 1
354 EATING DISORDER 1
355 ECCHYMOSIS 1
356 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1
357 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1
358 EMOTIONAL DISTRESS 1
359 ENCEPHALOPATHY 1
360 ENDOTRACHEAL INTUBATION COMPLICATION 1
361 EPHELIDES 1
362 ERUCTATION 1
363 EXOPHTHALMOS 1
364 EXPOSURE TO EXTREME TEMPERATURE 1
365 EYE ALLERGY 1
366 EYE COLOUR CHANGE 1
367 EYE COMPLICATION ASSOCIATED WITH DEVICE 1
368 EYE DISCHARGE 1
369 EYELID DISORDER 1
370 EYELID OEDEMA 1
371 EYELID PTOSIS 1
372 FACE INJURY 1
373 FACE OEDEMA 1
374 FACIAL PARALYSIS 1
375 FEEDING INTOLERANCE 1
376 FLATULENCE 1
377 GAIT DISTURBANCE 1
378 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 1
379 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
380 GENERAL PHYSICAL HEALTH DETERIORATION 1
381 GENERALISED TONIC-CLONIC SEIZURE 1
382 GLIOBLASTOMA 1
383 HAEMATOCRIT ABNORMAL 1
384 HAEMODYNAMIC INSTABILITY 1
385 HAEMOGLOBIN ABNORMAL 1
386 HAIR GROWTH ABNORMAL 1
387 HAIR TEXTURE ABNORMAL 1
388 HEMIPARESIS 1
389 HEMIPLEGIA 1
390 HEPATIC ENCEPHALOPATHY 1
391 HEPATOMEGALY 1
392 HERPES OPHTHALMIC 1
393 HIDRADENITIS 1
394 HORMONE LEVEL ABNORMAL 1
395 HOT FLUSH 1
396 HYDROCEPHALUS 1
397 HYPERAESTHESIA 1
398 HYPERCAPNIA 1
399 HYPERHIDROSIS 1
400 HYPERSOMNIA 1
401 HYPERTENSIVE EMERGENCY 1
402 HYPERVENTILATION 1
403 HYPOACUSIS 1
404 HYPONATRAEMIA 1
405 HYPOPHAGIA 1
406 HYPOXIA 1
407 ILEUS 1
408 ILL-DEFINED DISORDER 1
409 IMPAIRED WORK ABILITY 1
410 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
411 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
412 INFLUENZA 1
413 INJECTION SITE PAIN 1
414 INSTILLATION SITE ERYTHEMA 1
415 INTENTIONAL DOSE OMISSION 1
416 INTENTIONAL OVERDOSE 1
417 INTENTIONAL PRODUCT MISUSE 1
418 INTENTIONAL PRODUCT USE ISSUE 1
419 JOINT SWELLING 1
420 KERATOACANTHOMA 1
421 LETHARGY 1
422 LIMB IMMOBILISATION 1
423 LIP DISCOLOURATION 1
424 LIP DRY 1
425 LIVER FUNCTION TEST INCREASED 1
426 LUNG NEOPLASM MALIGNANT 1
427 LYMPHADENOPATHY 1
428 LYMPHOCYTE COUNT ABNORMAL 1
429 MACULAR DEGENERATION 1
430 MALIGNANT NEOPLASM PROGRESSION 1
431 MEDICAL DEVICE SITE BURN 1
432 MEDICAL DEVICE SITE ODOUR 1
433 MENINGITIS 1
434 MENINGITIS BACTERIAL 1
435 MENINGITIS VIRAL 1
436 METASTASES TO SPINAL CORD 1
437 MIGRAINE 1
438 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
439 MULTIPLE SCLEROSIS 1
440 MUSCLE SPASMS 1
441 MUSCLE TWITCHING 1
442 MUSCULAR WEAKNESS 1
443 MYOCARDIAL ISCHAEMIA 1
444 NASAL CONGESTION 1
445 NASAL OBSTRUCTION 1
446 NASAL OEDEMA 1
447 NASOPHARYNGITIS 1
448 NECROTISING RETINITIS 1
449 NEEDLE ISSUE 1
450 NERVOUSNESS 1
451 NEURALGIA 1
452 NEUROPATHY PERIPHERAL 1
453 NEUTROPHIL COUNT ABNORMAL 1
454 NO ADVERSE EVENT 1
455 OEDEMA 1
456 OFF LABEL USE OF DEVICE 1
457 ORAL HERPES 1
458 ORBITAL HAEMATOMA 1
459 OROPHARYNGEAL OEDEMA 1
460 OROPHARYNGEAL PAIN 1
461 OVERGROWTH BACTERIAL 1
462 PAIN IN EXTREMITY 1
463 PALPITATIONS 1
464 PANIC ATTACK 1
465 PARTIAL SEIZURES 1
466 PEMPHIGOID 1
467 PEMPHIGUS 1
468 PERIORAL DERMATITIS 1
469 PERIORBITAL DISORDER 1
470 PERIORBITAL OEDEMA 1
471 PERIORBITAL SWELLING 1
472 PERSONALITY CHANGE 1
473 PHARYNGEAL HYPOAESTHESIA 1
474 PHARYNGEAL OEDEMA 1
475 PHARYNGEAL SWELLING 1
476 PHOTODYNAMIC THERAPY 1
477 PLASMA CELL MYELOMA 1
478 PNEUMOCEPHALUS 1
479 PNEUMONIA ASPIRATION 1
480 PNEUMOTHORAX 1
481 PORPHYRIA ACUTE 1
482 POSTOPERATIVE WOUND INFECTION 1
483 PROCEDURAL PAIN 1
484 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
485 PRODUCT ADMINISTRATION INTERRUPTED 1
486 PRODUCT APPEARANCE CONFUSION 1
487 PRODUCT AVAILABILITY ISSUE 1
488 PRODUCT COLOUR ISSUE 1
489 PRODUCT CONTAINER SEAL ISSUE 1
490 PRODUCT DELIVERY MECHANISM ISSUE 1
491 PRODUCT DESIGN ISSUE 1
492 PRODUCT DISPENSING ISSUE 1
493 PRODUCT NAME CONFUSION 1
494 PRODUCT PRESCRIBING ISSUE 1
495 PSEUDOFOLLICULITIS 1
496 PSORIASIS 1
497 PULMONARY MASS 1
498 PULMONARY OEDEMA 1
499 PUNCTATE KERATITIS 1
500 RED BLOOD CELL COUNT ABNORMAL 1
501 REFUSAL OF TREATMENT BY PATIENT 1
502 RENAL CYST 1
503 RENAL DISORDER 1
504 RENAL FAILURE 1
505 RESTLESSNESS 1
506 RETINAL TEAR 1
507 ROSEOLA 1
508 SCREAMING 1
509 SEPSIS 1
510 SINUS BRADYCARDIA 1
511 SINUS PAIN 1
512 SKIN ABRASION 1
513 SKIN ATROPHY 1
514 SKIN DISORDER 1
515 SKIN HAEMORRHAGE 1
516 SKIN HYPOPIGMENTATION 1
517 SKIN LESION 1
518 SKIN SENSITISATION 1
519 SKIN TEXTURE ABNORMAL 1
520 SOMNOLENCE 1
521 SORDES 1
522 SPEECH DISORDER 1
523 SPONTANEOUS HAEMORRHAGE 1
524 SQUAMOUS CELL CARCINOMA OF SKIN 1
525 SUICIDE ATTEMPT 1
526 SUPERFICIAL INJURY OF EYE 1
527 SUSPECTED OFF LABEL USE 1
528 SUSPECTED PRODUCT QUALITY ISSUE 1
529 SYSTEMIC VIRAL INFECTION 1
530 TELANGIECTASIA 1
531 TEMPERATURE INTOLERANCE 1
532 THERAPY PARTIAL RESPONDER 1
533 THROAT TIGHTNESS 1
534 THROMBOTIC MICROANGIOPATHY 1
535 TOOTH DISCOLOURATION 1
536 TRANSIENT APHASIA 1
537 TRANSIENT GLOBAL AMNESIA 1
538 TREATMENT DELAYED 1
539 TRICHORRHEXIS 1
540 TRISMUS 1
541 TYPE 2 DIABETES MELLITUS 1
542 UNEVALUABLE EVENT 1
543 UNRESPONSIVE TO STIMULI 1
544 URINARY TRACT INFECTION 1
545 URINE KETONE BODY PRESENT 1
546 VASCULAR INJURY 1
547 VERTIGO POSITIONAL 1
548 VIRAL INFECTION 1
549 VISUAL ACUITY REDUCED 1
550 VISUAL FIELD DEFECT 1
551 VOMITING PROJECTILE 1
552 WEIGHT DECREASED 1
553 WEIGHT INCREASED 1
554 WOUND INFECTION 1
555 WOUND SECRETION 1
556 WRONG DEVICE USED 1